EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity

Marco Rosichini, Veronica Bordoni, Domenico Alessandro Silvestris, Davide Mariotti, Giulia Matusali, Antonella Cardinale, Giovanna Zambruno, Angelo Giuseppe Condorelli, Sara Flamini, Shirley Genah, Marialuigia Catanoso, Franca Del Nonno und 9 weitere

Journal of Allergy and Clinical Immunology · 2023-04 · 151 (4) · 911-921

DOI: 10.1016/j.jaci.2023.01.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-04. Verfasst von Marco Rosichini und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; Department of Molecular…. Hauptthemen laut MEDLINE: COVID-19, Lymphopenia. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lymphopenia, particularly when restricted to the T-cell compartment, has been described as one of the major clinical hallmarks in patients with coronavirus disease 2019 (COVID-19) and proposed as an indicator of disease severity. Although several mechanisms fostering COVID-19-related lymphopenia have been described, including cell apoptosis and tissue homing, the underlying causes of the decline in T-cell count and function are still not completely understood. OBJECTIVE: Given that viral infections can directly target thymic microenvironment and impair the process of T-cell generation, we sought to investigate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on thymic function. METHODS: We performed molecular quantification of T-cell receptor excision circles and κ-deleting recombination excision circles to assess, respectively, T- and B-cell neogenesis in SARS-CoV-2-infected patients. We developed a system for in vitro culture of primary human thymic epithelial cells (TECs) to mechanistically investigate the impact of SARS-CoV-2 on TEC function. RESULTS: We showed that patients with COVID-19 had reduced thymic function that was inversely associated with the severity of the disease. We found that angiotensin-converting enzyme 2, through which SARS-CoV-2 enters the host cells, was expressed by thymic epithelium, and in particular by medullary TECs. We also demonstrated that SARS-CoV-2 can target TECs and downregulate critical genes and pathways associated with epithelial cell adhesion and survival. CONCLUSIONS: Our data demonstrate that the human thymus is a target of SARS-CoV-2 and thymic function is altered following infection. These findings expand our current knowledge of the effects of SARS-CoV-2 infection on T-cell homeostasis and suggest that monitoring thymic activity may be a useful marker to predict disease severity and progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19LymphopeniaHumansSARS-CoV-2Thymus GlandPatient Acuity

Stichwörter der Autor:innen

COVID-19SARS-CoV-2T cellsimmunodeficiencythymic epithelial cellsthymus

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy; Cellular Immunology Laboratory, INMI L Spallanzani - IRCCS, Rome, Italy.
  • Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Cellular Immunology Laboratory, INMI L Spallanzani - IRCCS, Rome, Italy.
  • Virology Laboratory, INMI L Spallanzani - IRCCS, Rome, Italy.
  • Genodermatosis Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Zitieren

APA

Rosichini, M., Bordoni, V., Silvestris, D. A., Mariotti, D., Matusali, G., Cardinale, A., Zambruno, G., Condorelli, A. G., Flamini, S., Genah, S., Catanoso, M., Del Nonno, F., Trezzi, M., Galletti, L., De Stefanis, C., Cicolani, N., Petrini, S., Quintarelli, C., Agrati, C., …, & Velardi, E. (2023). SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity. Journal of Allergy and Clinical Immunology, 151(4), 911-921. https://doi.org/10.1016/j.jaci.2023.01.022

Vancouver

Rosichini M, Bordoni V, Silvestris DA, Mariotti D, Matusali G, Cardinale A, et al. SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity. Journal of Allergy and Clinical Immunology. 2023;151(4):911-921. doi:10.1016/j.jaci.2023.01.022

BibTeX
@article{Rosichini2023,
  author = {Rosichini, Marco and Bordoni, Veronica and Silvestris, Domenico Alessandro and Mariotti, Davide and Matusali, Giulia and Cardinale, Antonella and Zambruno, Giovanna and Condorelli, Angelo Giuseppe and Flamini, Sara and Genah, Shirley and Catanoso, Marialuigia and Del Nonno, Franca and Trezzi, Matteo and Galletti, Lorenzo and De Stefanis, Cristiano and Cicolani, Nicolò and Petrini, Stefania and Quintarelli, Concetta and Agrati, Chiara and Locatelli, Franco and Velardi, Enrico},
  title = {SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  volume = {151},
  number = {4},
  pages = {911--921},
  doi = {10.1016/j.jaci.2023.01.022}
}
Kostenlos starten →